Showing results (91-100 of 211) with videos related to
Sort By:
Pageof 22
Journal of the National Cancer Center|September 16, 2024
Guidelines for diagnosis and treatment of advanced breast cancer in China (2022 edition), , Journal of the National Cancer Center|September 16, 2024
Resolving tumor evolution: a phylogenetic approachLin Li, Wenqin Xie, Li Zhan, et al.Journal of the National Cancer Center|September 16, 2024
Concordance between four PD-L1 immunohistochemical assays and 22C3 pharmDx assay in esophageal squamous cell carcinoma in a multicenter studyLiyan Xue, Yuan Li, Lili Jiang, et al.Journal of the National Cancer Center|September 16, 2024
CAR-T in cancer therapeutics and updatesShigui ZhuJournal of the National Cancer Center|September 16, 2024
Deep learning model based on primary tumor to predict lymph node status in clinical stage IA lung adenocarcinoma: a multicenter studyLi Zhang, Hailin Li, Shaohong Zhao, et al.Journal of the National Cancer Center|September 16, 2024
Burden of malignant mesothelioma in China during 1990-2019 and the projections through 2029Qiulin Huang, Youli Chen, Liyou Lian, et al.Journal of the National Cancer Center|February 25, 2026
Clinicopathologic, genetic and immune cell infiltration analysis of colorectal signet ring cell carcinoma with comparison to conventional adenocarcinomaYang An, Jiaolin Zhou, Lan Su, et al.Journal of the National Cancer Center|June 12, 2026
Global patterns of upper gastrointestinal cancer incidence by subtype and subsite in 2022: a population-based studyYuanjie Zheng, Nuopei Tan, Yi Teng, et al.Journal of the National Cancer Center|April 20, 2026
Catching pancreatic cancer early: Are we there yet?Aminath Rana Abdul Rasheed, Rhun Yian Koh, Wei-Meng Lim, et al.Journal of the National Cancer Center|August 22, 2026
Orelabrutinib, fludarabine, cyclophosphamide, and obinutuzumab (OFCG) for first-line treatment of chronic lymphocytic leukemia: a multicenter phase II trial (cwCLL-001 trial)Yi Miao, Ming Liu, Shuchao Qin, et al.Pageof 22